1. Home
  2. HSAI vs AVXL Comparison

HSAI vs AVXL Comparison

Compare HSAI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSAI
  • AVXL
  • Stock Information
  • Founded
  • HSAI 2014
  • AVXL 2004
  • Country
  • HSAI China
  • AVXL United States
  • Employees
  • HSAI N/A
  • AVXL N/A
  • Industry
  • HSAI
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HSAI
  • AVXL Health Care
  • Exchange
  • HSAI Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • HSAI 504.8M
  • AVXL 484.2M
  • IPO Year
  • HSAI 2023
  • AVXL N/A
  • Fundamental
  • Price
  • HSAI $4.61
  • AVXL $9.02
  • Analyst Decision
  • HSAI
  • AVXL Strong Buy
  • Analyst Count
  • HSAI 0
  • AVXL 2
  • Target Price
  • HSAI N/A
  • AVXL $43.00
  • AVG Volume (30 Days)
  • HSAI 446.3K
  • AVXL 1.7M
  • Earning Date
  • HSAI 11-26-2024
  • AVXL 12-03-2024
  • Dividend Yield
  • HSAI N/A
  • AVXL N/A
  • EPS Growth
  • HSAI N/A
  • AVXL N/A
  • EPS
  • HSAI N/A
  • AVXL N/A
  • Revenue
  • HSAI $251,101,295.00
  • AVXL N/A
  • Revenue This Year
  • HSAI $19.66
  • AVXL N/A
  • Revenue Next Year
  • HSAI $46.79
  • AVXL N/A
  • P/E Ratio
  • HSAI N/A
  • AVXL N/A
  • Revenue Growth
  • HSAI 13.11
  • AVXL N/A
  • 52 Week Low
  • HSAI $3.28
  • AVXL $3.25
  • 52 Week High
  • HSAI $11.20
  • AVXL $10.45
  • Technical
  • Relative Strength Index (RSI)
  • HSAI 53.63
  • AVXL 67.91
  • Support Level
  • HSAI $4.02
  • AVXL $7.18
  • Resistance Level
  • HSAI $4.53
  • AVXL $10.45
  • Average True Range (ATR)
  • HSAI 0.23
  • AVXL 0.87
  • MACD
  • HSAI 0.01
  • AVXL 0.02
  • Stochastic Oscillator
  • HSAI 84.29
  • AVXL 62.66

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: